ArticleRegenerative therapy2026

First-in-human study to investigate the safety and efficacy of effective-mononuclear cell therapy for radiogenic xerostomia.

Takashi I et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.